Virax Biolabs

London, United Kingdom

Virax Biolabs is a biotechnology company focusing on the prevention, detection, and diagnosis of viral diseases.

$5.0M raised

Dec 2025

Post-IPO Equity

Biotechnology Health Diagnostics Life Science Medical Device

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Virax Biolabs

How much funding has Virax Biolabs raised?

Virax Biolabs has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.

Where is Virax Biolabs headquartered?

Virax Biolabs is headquartered in London, United Kingdom.

What does Virax Biolabs do?

Virax Biolabs is a biotechnology company focusing on the prevention, detection, and diagnosis of viral diseases.

What stage is Virax Biolabs at?

Virax Biolabs is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 3, 2025.

MLA

"Virax Biolabs — Funding & Investors." VCBacked, December 3, 2025, https://www.vcbacked.co/company/virax-biolabs. Accessed July 4, 2026.

APA

VCBacked. (2025). Virax Biolabs — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/virax-biolabs

Wikipedia (cite web)

{{cite web |title=Virax Biolabs — Funding & Investors |url=https://www.vcbacked.co/company/virax-biolabs |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 3, 2025.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K